Hefter, H.; Ürer, B.; Brauns, R.; Rosenthal, D.; Meuth, S.G.; Lee, J.-I.; Albrecht, P.; Samadzadeh, S.
Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure. Toxins 2022, 14, 44.
https://doi.org/10.3390/toxins14010044
AMA Style
Hefter H, Ürer B, Brauns R, Rosenthal D, Meuth SG, Lee J-I, Albrecht P, Samadzadeh S.
Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure. Toxins. 2022; 14(1):44.
https://doi.org/10.3390/toxins14010044
Chicago/Turabian Style
Hefter, Harald, Beyza Ürer, Raphaela Brauns, Dietmar Rosenthal, Sven G. Meuth, John-Ih Lee, Philipp Albrecht, and Sara Samadzadeh.
2022. "Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure" Toxins 14, no. 1: 44.
https://doi.org/10.3390/toxins14010044
APA Style
Hefter, H., Ürer, B., Brauns, R., Rosenthal, D., Meuth, S. G., Lee, J.-I., Albrecht, P., & Samadzadeh, S.
(2022). Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure. Toxins, 14(1), 44.
https://doi.org/10.3390/toxins14010044
